MS Speaks

Multiple Sclerosis => GENERAL DISCUSSION - RESEARCH, NEWS => Topic started by: agate on May 15, 2019, 04:14:03 pm

Title: (AAN) Biogen says new MS drug Vumerity (diroximel fumarate, BIIB098) under FDA review
Post by: agate on May 15, 2019, 04:14:03 pm
Neurofilament light chains received quite a bit of attention at the annual AAN conference for 2019 (Philadelphia, May 4-10). They're mentioned in this article from Multiple Sclerosis News Today (May 15, 2019) entitled "Biogen Offers Update on Development Plans for MS Therapies." The Biogen spokesperson is announcing another new MS drug, Vumerity, which is up for FDA review:


http://bit.ly/2vZW9t9